Digital therapeutics have shown how therapy can be delivered effectively through a digital interface, but the bankruptcy of Pear Therapeutics raised questions about whether these technologies can be commercially successful. A panel at the MedCity News INVEST Digital Health conference discussed the promise and pitfalls of these emerging technologies.
A significant recognition of the groundbreaking approach of the Digital Medicines and Digital Therapeutic company Newel Health announced today that it was selected to receive a grant from The Michael
Digital medicines, which span chronic conditions, mental health issues such as depression, anxiety, and addiction, is just one of the topics that will be offered at MedCity INVEST PharmaTech, a virtual conference scheduled for July 26. Learn how to take part or register today.
Press ReleaseNicox Appoints Doug Hubatsch as new Chief Scientific Officer to lead Clinical and Non-clinical DevelopmentDecember 13, 2021- release at 7:30 am CET Sophia Antipolis, FranceNicox SA (Euronext